Currae Healthtech Fund

Currae concentrates on early-stage healthcare companies in India, spanning healthcare delivery chains, medical device manufacturers, and digital health platforms. The firm targets pre-Series A and Series A rounds, where specialist healthcare capital is scarcest. It does not invest outside the healthcare sector.

The firm leverages a domain-specific origination network built on relationships with hospital administrators, medical device distributors, clinical societies, and healthcare entrepreneurs. This specialist sourcing model is designed to surface opportunities that generalist venture funds, lacking healthcare-specific diligence capabilities, often overlook or cannot properly underwrite.

Currae typically leads or co-leads the rounds it participates in, taking board seats and providing hands-on operational support. Areas of active involvement include clinical protocol standardization, regulatory strategy with bodies like CDSCO, and structuring partnerships with large hospital groups for pilot deployments.

The identities of Currae's managing partners and investment committee members are not publicly documented in standard corporate registries or the firm's own digital footprint. The fund operates with a low public profile, consistent with many India-domiciled sector-specialist vehicles.

The firm invests pan-India, with a concentration in major metropolitan healthcare markets — Mumbai, Bangalore, and Delhi NCR — where hospital infrastructure, specialist clinician density, and healthtech entrepreneurial activity are highest. It evaluates opportunities in tier-2 cities when the unit economics and clinical need support a scalable model.